Zeo ScientifiX, Inc.

ZEOX · OTC · SIC 2836: Biological Products, (No Diagnostic Substances)
211
SEC Filings
$0.9089
Close 2026-11-06

Business Summary

Zeo ScientifiX, Inc. is a clinical-stage biopharmaceutical company developing biological therapeutics for degenerative diseases and regenerative medicine. Its principal products include Zofin, derived from amniotic fluid retaining extracellular vesicles, proteins, and cell secreted nanoparticles, and Patient Pure X (PPX), an autologous biologic precipitated from a patient's own peripheral blood. The company also distributes topical aesthetic products incorporating proprietary ingredients. All products are manufactured in FDA-registered, cGMP-compliant facilities in Davie, Florida. The company is pursuing clinical trials and commercial sales strategies aligned with Florida's SB 1768 stem cell therapy law for orthopedic, wound care, and pain management indications.

Latest Stock Quote

ZEOX 2026-11-06 $0.9089 O:$0.9089 H:$0.9089 L:$0.9089 Vol:0.0M VWAP:$0.9089
origin leaf: null

Next Earnings

expected 2027-01-29

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-01-292025-10-310001829126-26-000763EDGAR65K words
2025-01-292024-10-310001829126-25-000536EDGAR58K words
2024-01-292023-10-310001829126-24-000541EDGAR71K words
2023-02-142022-10-310001829126-23-001524EDGAR77K words
2022-02-142021-10-310001829126-22-003605EDGAR75K words
2021-02-082020-10-310001829126-21-000414EDGAR64K words
2020-10-162019-10-310001683168-20-003466EDGAR84K words
2020-03-062018-10-310001683168-20-000712EDGAR98K words
2018-11-012017-10-310001683168-18-003206EDGAR95K words
2017-07-072016-10-310001493152-17-007610EDGAR83K words

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-03-172026-01-310001829126-26-002396EDGAR17K words
2025-09-152025-07-310001829126-25-007398EDGAR21K words
2025-06-162025-04-300001829126-25-004512EDGAR19K words
2025-03-172025-01-310001829126-25-001828EDGAR15K words
2024-09-162024-07-310001829126-24-006296EDGAR19K words
2024-06-142024-04-300001829126-24-004217EDGAR17K words
2024-03-182024-01-310001829126-24-001677EDGAR14K words
2023-09-142023-07-310001829126-23-006098EDGAR24K words
2023-06-162023-04-300001829126-23-004245EDGAR23K words
2023-03-172023-01-310001829126-23-002113EDGAR18K words
2022-09-142022-07-310001829126-22-016867EDGAR27K words
2022-06-142022-04-300001829126-22-013532EDGAR21K words

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-11-030001829126-26-011913EDGAR2K words
2026-10-300001829126-26-011800EDGAR27K words
2026-10-260001829126-26-011497EDGAR1K words
2026-09-150001829126-26-010100EDGAR1K words
2026-09-150001829126-26-010114EDGAR1K words
2026-09-010001829126-26-009583EDGAR1K words
2026-08-040001829126-26-008299EDGAR1K words
2026-07-210001829126-26-007689EDGAR1K words
2026-03-310001829126-26-002881EDGAR1K words
2026-03-270001829126-26-002789EDGAR0K words

211 total filings indexed. 179 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ARGX — ARGENX SE

Tags

regenerative-medicine degenerative-disease-treatment orthopedic wound-care pain-management topical-aesthetics-and-anti-aging musculoskeletal-joint-pathologies cgmp-(current-good-manufacturing-practice) fda-registered-laboratory-facilities section-351-public-health-services-act-(hct/ps) biologics-license-application-(bla) investigational-new-drug-(ind)-/-eind institutional-review-board-(irb)-approval

Company Identity

CIK0001557376
TickerZEOX
ExchangeOTC
SIC2836: Biological Products, (No Diagnostic Substances)
IncorporatedNV
HeadquartersDavie, Florida

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: 04c5e366a8d320eb03bc8861d611887685991e0bcc3848b52aaa4d3ac9e26f25
parent: 4682193e337b76cc2cf987d958bc9a5dfc438e21e7836a0f7e5546fb1b1a1bcd
content hash: a7dfc317ba31cd6572cd3a666a0b49fdadae5855c43dbb6009e72735653c38d2
signed: 2026-11-16T19:05:44.662Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up ZEOX using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on ZEOX, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/ZEOX (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.